Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Medifast Q4 Adj $0.10 Beats $(0.16) Estimate, Sales $119.00M Beat $114.25M Estimate

Author: Benzinga Newsdesk | February 18, 2025 04:18pm
Medifast (NYSE:MED) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.16) by 162.5 percent. This is a 90.83 percent decrease over earnings of $1.09 per share from the same period last year. The company reported quarterly sales of $119.00 million which beat the analyst consensus estimate of $114.25 million by 4.16 percent. This is a 37.70 percent decrease over sales of $191.01 million the same period last year.

Posted In: MED

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist